Synairgen Share News (SNG)
SNG Share
SNG Share
SNG Share
SNG Share
SNG
SNG Share
SNG Level 2
SNG Live
SNG Broker
SNG Directors
SNG Financial
SNG
SNG Short
SNG
Last checked at -
Tue, 21st Oct 2014 08:50
Synairgen, a Southampton-based research firm, has placed around 5.56m shares at 45p each, enabling the firm to progress with its primary programme following the successful clinical trial results of an asthma treatment product. The placing has raised £2.5m before expenses. In a related transaction,
Read moreSouthampton based research firm, Synairgen, has rocketed in morning trading after announcing results for a treatment which could protect asthmatics from respiratory virus infections. The drug, called SNG001, stops infections like the common cold spreading to patients' lungs, which is often the caus
Read moreHold on tight, a wave of patent expiries and generic competition could spark another round of consolidation in the pharma and medical devices sector this year. Billions of dollars have been spent on takeovers or pumped into new issues in recent months as confidence in the recovery grows and cash-ri
Read moreShares in Plantic Technologies soared more than 50% after the biodegradeable plastics outfit agreed an 8p per share offer from a company controlled by Gordon Merchant, one of its directors. Acal, which provides technology products and services across Europe and South Africa, said underlying sales
Read moreLONDON (Dow Jones)--Synairgen PLC (SNG.LN), a respiratory drug discovery and development company with a particular focus on viral defense, Thursday reported a full year net loss of GBP2.6 million, compared with a loss of GBP2.5 million the previous year. MAIN FACTS: -Research and development
Read morePR specialist Freshwater cut the dividend as profits fell to £32,000 from £106,000 in the six months to end February. Revenues fell to £3.66m from £4.51m. "While the economic environment remains challenging, Freshwater is seeing greater stability and growth potential in most of its markets. Alongsi
Read moreGriffin Mining posted a rise in profits in the year to December 31 despite a slide in revenues following the collapse in metals prices in late 2008. The company, which operates the Caijiaying zinc-gold mine in China, posted a pre-tax profit of $7.2m, up from $7m in 2008, even as revenues fell to $2
Read moreMining stocks were at the vanguard of a strong advance from FTSE 100 as commodity prices were boosted by plans outlined by world leaders over the weekend to continue with stimulus measures. Kazakhmys, Fresnillo, Rio Tinto and Vedanta were some of the best performers in the mining sector. Mining g
Read moreAfter all the waiting and speculation, the formal bid for Cadbury from US group Kraft Foods proved a disappointment, but it has not dampened sentiment in a buoyant London market. Kraft formally announced a bid for Cadbury on the same terms as the indicative offer announced at the beginning of Septe
Read moreThe share price of respiratory disease drug developer Synairgen more than doubled in early trading on Monday after positive developments for its inhaled interferon beta programme. Laboratory experiments confirmed the antiviral potency of IFN-beta against 2009 H1N1, better known as ‘swine flu’. The
Read moreZimbabwe-focused investment company LonZim said it is well-placed to benefit from any upturn in the southern African country's economy after investing in several sectors in the six months to February 28. The company posted a pre-tax loss of £911,000 as it invested in telecoms, aviation and hotel se
Read more
Last checked at